Integrative genomics: Quantifying significance of phenotype-genotype relationships from multiple sources of high-throughput data

Frontiers in Genetics

Volumn 4, Issue MAY, 2013, Pages

  Gamazon, Eric R ^a   Stephanie Huang, R ^a   Eileen Dolan, M ^a   Cox, Nancy J ^a   Im, Hae Kyung ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

eQTLs; FDR; Gene expression; Genomics; Gwas; Integrative genomics; Permutation; Phenotype

Indexed keywords

EID: 84883501344     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2012.00202     Document Type: Article

References (39)

1. Cheung, V. G., Conlin, L. K., Weber, T. M., Arcaro, M., Jen, K. Y., Morley, M., et al. (2003). Natural variation in human gene expression assessed in lymphoblastoid cells. Nat. Genet. 33, 422-425.
2. Correa, C. R., and Cheung, V. G. (2004). Genetic variation in radiation-induced expression phenotypes. Am. J. Hum. Genet. 75, 885-890.
3. Degner, J. F., Pai, A. A., Pique-Regi, R., Veyrieras, J. B., Gaffney, D. J., Pickrell, J. K., et al. (2012). DNase I sensitivity QTLs are a major determinant of human expression variation. Nature 482, 390-394.
4. Dermitzakis, E. T. (2012). Cellular genomics for complex traits. Nat. Rev. Genet. 13, 215-220.
5. Duan, S., Huang, R. S., Zhang, W., Bleibel, W. K., Roe, C. A., and Clark, T. A. (2008). Genetic architecture of transcript-level variation in humans. Am. J. Hum. Genet. 82, 1101-1113.
6. Farnham, P. J. (2009). Insights from genomic profiling of transcription factors. Nat. Rev. Genet. 10, 605-616.
7. Gamazon, E. R., Huang, R. S., Cox, N. J., and Dolan, M. E. (2010a). Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci. Proc. Natl. Acad. Sci. U.S.A. 107, 9287-9292.
8. Gamazon, E. R., Zhang, W., Konkashbaev, A., Duan, S., Kistner, E. O., Nicolae, D. L., et al. (2010b). SCAN: SNP and copy number annotation. Bioinformatics 26, 259-262.
9. Gamazon, E. R., Ziliak, D., Im, H. K., LaCroix, B., Park, D. S., Cox, N. J., and Huang, R. S. (2012). Genetic architecture of microRNA expression: implications for the transcriptome and complex traits. Am. J. Hum. Genet. 90, 1046-1063.
10. Garge, N., Pan, H., Rowland, M. D., Cargile, B. J., Zhang, X., Cooley, P. C., et al. (2010). Identification of quantitative trait loci underlying proteome variation in human lymphoblastoid cells. Mol. Cell Proteomics 9, 1383-1399.
11. Hajji, N., Wallenborg, K., Vlachos, P., Füllgrabe, J., Hermanson, O., and Joseph, B. (2010). Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide. Oncogene 29, 2192-2204.
12. Hajji, N., Wallenborg, K., Vlachos, P., Nyman, U., Hermanson, O., and Joseph, B. (2008). Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells. Oncogene 27, 3134-3144.
13. Hawkins, R. D., Hon, G. C., and Ren, B. (2010). Next-generation genomics: an integrative approach. Nat. Rev. Genet. 11, 476-486.
14. Hindorff, L. A., Sethupathy, P., Junkins, H. A., Ramos, E. M., Mehta, J. P., Collins, F. S., et al. (2009). Potential etiologic, and functional implications of genome-wide association loci for human diseases, and traits. Proc. Natl. Acad. Sci. U.S.A. 106, 9362-9367.
15. Huang, R. S., Duan, S., Shukla, S. J., Kistner, E. O., Clark, T. A., Chen, T. X., et al. (2007a). Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am. J. Hum. Genet. 81, 427-437.
16. Huang, R. S., Duan, S., Bleibel, W. K., Kistner, E. O., Zhang, W., Clark, T. A., et al. (2007b). A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 104, 9758-9763.
17. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57.
18. Ko, D. C., Shukla, K. P., Fong, C., Wasnick, M., Brittnacher, M. J., Wurfel, M. M., et al. (2009). A genome-wide in vitro bacterial-infection screen reveals human variation in the host response associated with inflammatory disease. Am. J. Hum. Genet. 85, 214-227.
19. Kurz, E. U., Wilson, S. E., Leader, K. B., Sampey, B. P., Allan, W. P., Yalowich, J. C., et al. (2001). The histone deacetylase inhibitor sodium butyrate induces DNA topoisomerase II alpha expression and confers hypersensitivity to etoposide in human leukemic cell lines. Mol. Cancer Ther. 1, 121-131.
20. Laird, P. W. (2010). Principles and challenges of genomewide DNA methylation analysis. Nat. Rev. Genet. 11, 191-203.
21. Marchion, D. C., Bicaku, E., Daud, A. I., Richon, V., Sullivan, D. M., and Munster, P. N. (2004). Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid. J. Cell. Biochem. 92, 223-237.
22. Metzker, M. L. (2010). Sequencing technologies - the next generation. Nat. Rev. Genet. 11, 31-46.
23. Mistry, A. R., Felix, C. A., Whitmarsh, R. J., Mason, A., Reiter, A., Cassinat, B., et al. (2005). DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N. Engl. J. Med. 352, 1529-1538.
24. Montgomery, S. B., Sammeth, M., Gutierrez-Arcelus, M., Lach, R. P., Ingle, C., Nisbett, J., et al. (2010). Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 464, 773-777.
25. Nica, A. C., Montgomery, S. B., Dimas, A. S., Stranger, B. E., Beazley, C., Barroso, I., et al. (2010). Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations. PLoS Genet. 6:e1000895. doi:10.1371/journal.pgen.1000895
26. Nicolae, D. L., Gamazon, E., Zhang, W., Duan, S., Dolan, M. E., and Cox, N. J. (2010). Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 6:e1000888. doi:10.1371/journal.pgen.1000888
27. Peters, E. J., Motsinger-Reif, A., Havener, T. M., Everitt, L., Hardison, N. E., Watson, V. G., et al. (2011). Pharmacogenomic characterization of US FDA-approved cytotoxic drugs. Pharmacogenomics 12, 1407-1415.
28. Pickrell, J. K., Marioni, J. C., Pai, A. A., Degner, J. F., Engelhardt, B. E., Nkadori, E., et al. (2010). Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464, 768-772.
29. Schadt, E. E., Molony, C., Chudin, E., Hao, K., Yang, X., Lum, P. Y., et al. (2008). Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6:e107. doi:10.1371/journal.pbio.0060107
30. Sinha, B. K., Haim, N., Dusre, L., Kerrigan, D., and Pommier, Y. (1988). DNA strand breaks produced by etoposide (VP-16,213) in sensitive and resistant human breast tumor cells: implications for the mechanism of action. Cancer Res. 48, 5096-5100.
31. Storey, J. D. (2003). The positive false discovery rate: a Bayesian interpretation and the q-value. Ann. Stat. 31, 2013-2035.
32. Storey, J. D., and Tibshirani, R. (2003). Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U.S.A. 100, 9440-9445.
33. Stranger, B. E., Forrest, M. S., Dunning, M., Ingle, C. E., Beazley, C., Thorne, N., et al. (2007a). Relative impact of nucleotide, and copy number variation on gene expression phenotypes. Science 315, 848-853.
34. Stranger, B. E., Nica, A. C., Forrest, M. S., Dimas, A., Bird, C. P., Beazley, C., et al. (2007b). Population genomics of human gene expression. Nat. Genet. 39, 1217-1224.
35. Stranger, B. E., Montgomery, S. B., Dimas, A. S., Parts, L., Stegle, O., Ingle, C. E., et al. (2012). Patterns of cis regulatory variation in diverse human populations. PLoS Genet. 8:e1002639. doi:10.1371/journal.pgen.1002639
36. Wang, Z., Gerstein, M., and Snyder, M. (2009). RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57-63.
37. Welsh, M., Mangravite, L., Medina, M. W., Tantisira, K., Zhang, W., Huang, R. S., et al. (2009). Pharmacogenomic discovery using cell-based models. Pharmacol. Rev. 61, 413-429.
38. Zhong, H., Beaulaurier, J., Lum, P. Y., Molony, C., Yang, X., Macneil, D. J., et al. (2010). Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet. 6:e1000932. doi:10.1371/journal.pgen.1000932
39. Zhou, V. W., Goren, A., and Bernstein, B. E. (2011). Charting histone modifications and the functional organization of mammalian genomes. Nat. Rev. Genet. 12, 7-18.